Sabiad B.V., in collaboration with the University Medical Center Groningen (UMCG), is developing and validating a sensitive, specific, and rapid point-of-care test for the detection of Staphylococcus aureus (SA) bacteria.
This detection test identifies the presence of SA in a patient’s synovial fluid (joint fluid) and is being advanced from Technology Readiness Level (TRL) 5 to 7. The project aims to validate a near-market prototype through both retrospective and prospective testing using patient samples, with contributions from regional hospitals MCL, Martini Hospital, and Isala as third parties.
Expected outcomes include the publication of scientific articles, the training of a researcher at UMCG, the creation of a new clinical learning case for medical education at UMCG, and the dissemination of results at major scientific conferences and symposia.
Sabiad has received €296,979,71 in funding for this project.
This project is co-funded by the European Union.
